Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/13/1993 | CA2122491A1 Tgf-.beta. type receptor cdnas and uses therefor |
05/13/1993 | CA2122359A1 Antigen associated with type i diabetes mellitus |
05/13/1993 | CA2122261A1 Modified genes and their expression in plant cells |
05/13/1993 | CA2121352A1 Novel thrombin-inhibitory protein from assassin bugs |
05/13/1993 | CA2121246A1 Novel thrombin-inhibitory protein from ticks |
05/13/1993 | CA2117268A1 Novel coleopteran-active bacillus thuringiensis isolates and genes encoding coleopteran-active toxins |
05/13/1993 | CA2117267A1 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
05/12/1993 | EP0541418A1 Preparation of antigens and vaccines of the mystery disease virus, obtained antigens and vaccines for the prevention of this disease |
05/12/1993 | EP0541335A1 Recombinant DNA sequences and plasmids for cellular immunity vaccines from bacterial toxinantigen conjugates |
05/12/1993 | EP0541089A2 cDNA of human hepatitis C virus, its clone and use thereof |
05/12/1993 | EP0541058A1 Expression of a mature proteinase 2a, its partial purification and preparation of inhibitory active substrates |
05/12/1993 | EP0540997A1 Methods and reagents for HLA class I DNA typing |
05/12/1993 | EP0540784A1 Dye transfer inhibiting compositions |
05/12/1993 | EP0540719A1 Dictyostelid expression vector and method for expressing a desired protein |
05/12/1993 | EP0540709A1 Novel antipathogenic peptides and compositions containing same |
05/12/1993 | EP0540693A1 THE REDUCTION OF NON-SPECIFIC AMPLIFICATION DURING $i(IN VITRO) NUCLEIC ACID AMPLIFICATION USING MODIFIED NUCLEIC ACID BASES |
05/12/1993 | EP0540687A1 Antibody-mediated cofactor-driven reactions |
05/12/1993 | EP0540675A1 Inhibition of mac-1 receptor binding to fibrinogen using d 30? homologs |
05/12/1993 | EP0540651A1 Endogenously sweetened transgenic plant products |
05/12/1993 | EP0540650A1 Gamma-carboxylase and methods of use |
05/12/1993 | EP0540645A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
05/12/1993 | EP0540586A1 Binding domains |
05/12/1993 | EP0540585A1 Competitive pcr for quantitation of dna. |
05/12/1993 | EP0540573A1 Assay of free and complexed prostate-specific antigen (psa). |
05/12/1993 | EP0540561A1 Binary cryptocytotoxic method of hybrid seed production |
05/12/1993 | EP0540525A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
05/12/1993 | EP0525054A4 Modified heparin binding growth factors |
05/12/1993 | EP0217822B1 Human metallothionein-ii promoter in mammalian expression system |
05/12/1993 | EP0160670B1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
05/12/1993 | CN1071955A Mycobacterium primers and probes |
05/12/1993 | CN1071930A Inhibitors of hiv protease useful for treatment of aids |
05/12/1993 | CA2082577A1 Expression system |
05/12/1993 | CA2082450A1 Hybrid transforming growth factors |
05/11/1993 | US5210189 Chill resistant plants, bioengineering |
05/11/1993 | US5210180 Nonapeptides |
05/11/1993 | US5210036 Purified thermostable DNA polymerase obtainable from thermococcus litoralis |
05/11/1993 | US5210035 Non-reventing live vaccines |
05/11/1993 | US5210028 Process for the production of unfused igf-ii protein in e. coli |
05/11/1993 | US5210027 DNA encoding novel antimicrobial polypeptide and methods for obtaining such polypeptide |
05/11/1993 | US5210026 Human mk gene and method of expression |
05/11/1993 | US5210025 Culturing escherichia coli transformed with genetic vectors in the presence of transcriptional inducing agents |
05/11/1993 | US5210024 Isolation of strains of Saccharomyces cerevisiae having altered α-acetyltransferase activity |
05/11/1993 | US5210017 Ligand-mediated immunofunctional hormone binding protein assay method |
05/11/1993 | US5210015 Polymerase chain reaction technique |
05/11/1993 | CA1317557C Breast tumor-associated antigen and monoclonal antibodies specific thereto |
05/11/1993 | CA1317535C Assay of sequences using amplified genes |
05/09/1993 | WO1993009247A1 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
05/09/1993 | WO1993009239A1 Adeno-associated virus-2 basal vectors |
05/09/1993 | CA2100060A1 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
05/09/1993 | CA2082226A1 Polypeptide, dna fragment encoding the same, drug composition containing the same and process for producing the same |
05/09/1993 | CA2081952A1 Recombinant dna sequences and plasmids for cellular immunity vaccines from bacterial toxin-antigen conjugates, and methods of their use |
05/08/1993 | WO1993009253A1 Epitope mapping ot the c33c region of hcv |
05/08/1993 | CA2099883A1 Epitope mapping of the c33c region of hcv |
05/07/1993 | CA2082217A1 Expression of mature proteinase 2a, the partial purification thereof and preparation of substrates having an inhibitory effect |
05/06/1993 | DE4136087A1 Neues thrombininhibitorisches protein aus zecken Tick novel thrombin protein from |
05/06/1993 | CA2081582A1 Methods and reagents for hla class i dna typing |
05/05/1993 | EP0540457A1 Improvements in Borrelia burgdorferi diagnosis and prophylaxis |
05/05/1993 | EP0540314A1 Monoclonal antibodies to polyacrylate polymers |
05/05/1993 | EP0540263A1 Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form |
05/05/1993 | EP0540210A1 Novel bioprocesses for preparing 7-aca and 7-adac |
05/05/1993 | EP0540170A1 Silicon tetrahydrazides and purification of DNA |
05/05/1993 | EP0540135A2 Attenuated measles vaccine virus strain containing specific nucleotide sequence and a method for its absolute identification |
05/05/1993 | EP0540128A1 Nematode vaccine |
05/05/1993 | EP0540074A1 Cloning and sequencing of that chromosomal DNA region of bacillus subtilis comprising the SRFA operon which encodes the multienzymatic complex surfactin synthetase |
05/05/1993 | EP0540065A1 Retinoic acid receptor composition |
05/05/1993 | EP0540064A1 Apoaequorin peptides, recombinant DNA vectors capable of expressing the same and microorganisms containing said vectors |
05/05/1993 | EP0539970A2 Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby |
05/05/1993 | EP0539748A1 Polypeptides capable of binding to heavy chains of IL-2 receptors |
05/05/1993 | EP0539590A1 Plasmid containing dna which codes for the amino acid sequence of tcf-ii, transformed cell, and production of physiologically active substance by using the same |
05/05/1993 | EP0539573A1 Genomic modifications with homologous dna targeting |
05/05/1993 | EP0539563A1 Method of creating a transformed rice plant |
05/05/1993 | EP0539530A1 Purification directed cloning of peptides |
05/05/1993 | EP0539518A1 Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
05/05/1993 | EP0539515A1 Non-corrosive composition and methods useful for the extraction of nucleic acids |
05/05/1993 | EP0539492A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
05/05/1993 | EP0539490A1 Library screening method. |
05/05/1993 | EP0539466A1 Pt-CONTAINING COMPOUND, PROCESS FOR ITS PREPARATION, AND APPLICATION OF SUCH COMPOUNDS. |
05/05/1993 | EP0539455A1 Multivalent anti-cytokine immunoglobulins |
05/05/1993 | EP0539414A1 Stable and bioactive modified somatotropins |
05/05/1993 | EP0539395A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
05/05/1993 | EP0539371A1 Triple helix formation in oligonucleotide therapy |
05/05/1993 | EP0539366A1 Methods for detecting human leukemias |
05/05/1993 | EP0527806A4 Epithelins: novel cysteine - rich growth modulating proteins |
05/05/1993 | EP0515569A4 Calcium channel compositions and methods |
05/05/1993 | EP0511302A4 Cytotoxic cell-specific protease-related molecules and methods |
05/05/1993 | EP0500799A4 Particle-mediated transformation of animal tissue cells |
05/05/1993 | EP0491867A4 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
05/05/1993 | EP0486526A4 Tumour necrosis factor binding ligands |
05/05/1993 | EP0211077B1 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same |
05/05/1993 | CN1071586A Receptor of mutation growth factor use as pharmaceutical and application for treating cancer |
05/05/1993 | CN1020473C Dna clones coding for polypeptides exhibiting human graulocyte macrophage and eosinophil cellular growth factor activity |
05/05/1993 | CN1020472C Mammalian interleukin-4 |
05/05/1993 | CA2081990A1 Antibodies specific for rar-gamma or a specific isoform of rar-gamma |
05/04/1993 | US5208218 T cell growth factor glycoproteins |
05/04/1993 | US5208158 Oxidation stable detergent enzymes |
05/04/1993 | US5208157 Cloning the TaqI restriction and modification genes |
05/04/1993 | US5208149 Regulating gene expression |
05/04/1993 | US5208144 Genetic engineering and hybridization |
05/04/1993 | US5208041 Essentially pure human parathyroid hormone |
05/04/1993 | US5208036 Complexing a liposomal composition with a quaternary ammonium diether |